FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616815974> ?p ?o ?g. }

• W2616815974 endingPage "S56" @default.
• W2616815974 startingPage "S55" @default.
• W2616815974 abstract "Introduction: Following transplantation, many transplant programs employ induction immunosuppression, a relatively intense prophylactic therapy used at the time of transplant to prevent early acute rejection. Of the induction drugs, the interleukin-2 receptor (CD25) antagonist basiliximab (BXM) is frequently used. The targets of BXM are activated effector T cells, that upregulate CD25 upon activation and undergo IL-2 mediated T-cell proliferation, compromising allograft survival [1]. However, regulatory T cells (Treg) also express high levels of CD25 constitutively, and they rely on CD25 not only for their own proliferation and survival but also for detection of excessive proliferation of effector cells [2][3]. Therefore, BXM may be able to prevent acute rejection by hindering IL-2 mediated T effector expansion, but it could also compromise the likelihood of tolerance by impairing Treg proliferation and function. Methods: We enrolled 6 children who received a heart transplant and were treated with an established immunosuppression regimen. Two of the children were treated with BXM (20 mg on Day 0 and +4 after transplant), and 4 children did not receive BXM as induction therapy. We performed an exhaustive immunologic analysis at different time points including Tregs to analyze the effect of BXM on immune cells. Results: We show that the use of BXM during the first 4 days post-transplant completely blocks CD25 on T cells including Tregs for at least 45 days. Moreover, Treg numbers and Foxp3 expression were decreased in BXM-treated patients compared to patients not treated with BXM. We confirm the direct effect of BXM on Tregs by treating in vitro PBMC from healthy donors with BXM (n = 6). Basiliximab produced a marked Treg deregulation inducing a decrease in Foxp3 expression, a reduction in IL-10 production and a diminution in Treg proliferation under α-CD3/α-CD28 activation. Treg cells were more sensitive to the inhibitory effect of BXM than total CD4+ or CD8+ T cells. Conclusion: The use of basiliximab induction in transplanted children could compromise Treg-mediated tolerance during the first months post-transplant, which is the period with highest incidence of acute rejection, and could contribute to deregulation of immune homeostasis. This impact of BXM must be considered when making clinical decisions regarding induction immunosuppression.FIGURE 1: Frequency of Foxp3+CD25+CD4+ Treg cells in heart transplated children receiving induction therapy with Basiliximab (+BXM, n=2), or patients not treated with basilimab (-BXM, n=4). Mean values ±SEM are showed.This work was supported by grants from Instituto de Salud Carlos III (ISCIII) co-financed by FEDER funds (PI15/00011; ICI14/00282).FIGURE 2: Changes (%) from pre-transplant values (BL=0) in absolute counts (cells per uL of blood) of Foxp3+CD4+ cells in heart transplanted children receiving induction therapy with basilimab (+BXM, n=2), or patients not treated with basiliximab (-BXM, n=4). Mean values ±SEM are showed.FIGURE 3: CFrequencies of CDA+Foxp3+ (Treg) cells, CD4+ and CD8+ T cells within untreated (clear box) or BXM treated (solid box) PBMC stimulated with anti-CD3/CD28 dynabeads for 72h. Average and error bars indicating the 90th and 10th percentiles of 6 experiments are represented. *=<0.05 when comparing BXM-treated and non treated conditions.References: 1. Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation. 1999;67(2):276-84. 2. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-87. 3. Mendez-Lagares G, Jaramillo-Ruiz D, Pion M, Leal M, Munoz-Fernandez MA, Pacheco YM, et al. HIV infection deregulates the balance between regulatory T cells and IL-2-producing CD4 T cells by decreasing the expression of the IL-2 receptor in Treg. J Acquir Immune Defic Syndr. 2014;65(3):278-82." @default.
• W2616815974 created "2017-05-26" @default.
• W2616815974 creator A5010836395 @default.
• W2616815974 creator A5014181113 @default.
• W2616815974 creator A5038480610 @default.
• W2616815974 creator A5043391533 @default.
• W2616815974 creator A5054910534 @default.
• W2616815974 creator A5066668354 @default.
• W2616815974 creator A5080383668 @default.
• W2616815974 creator A5081762808 @default.
• W2616815974 creator A5082591171 @default.
• W2616815974 creator A5085854103 @default.
• W2616815974 date "2017-05-01" @default.
• W2616815974 modified "2023-09-23" @default.
• W2616815974 title "Induction Therapy With Basiliximab in Heart-Transplanted Children Impairs Regulatory T-Cell Population (Treg)" @default.
• W2616815974 doi "https://doi.org/10.1097/01.tp.0000520385.29688.0a" @default.
• W2616815974 hasPublicationYear "2017" @default.
• W2616815974 type Work @default.
• W2616815974 sameAs 2616815974 @default.
• W2616815974 citedByCount "0" @default.
• W2616815974 crossrefType "journal-article" @default.
• W2616815974 hasAuthorship W2616815974A5010836395 @default.
• W2616815974 hasAuthorship W2616815974A5014181113 @default.
• W2616815974 hasAuthorship W2616815974A5038480610 @default.
• W2616815974 hasAuthorship W2616815974A5043391533 @default.
• W2616815974 hasAuthorship W2616815974A5054910534 @default.
• W2616815974 hasAuthorship W2616815974A5066668354 @default.
• W2616815974 hasAuthorship W2616815974A5080383668 @default.
• W2616815974 hasAuthorship W2616815974A5081762808 @default.
• W2616815974 hasAuthorship W2616815974A5082591171 @default.
• W2616815974 hasAuthorship W2616815974A5085854103 @default.
• W2616815974 hasConcept C126322002 @default.
• W2616815974 hasConcept C203014093 @default.
• W2616815974 hasConcept C2776090121 @default.
• W2616815974 hasConcept C2777702733 @default.
• W2616815974 hasConcept C2778296632 @default.
• W2616815974 hasConcept C2779727006 @default.
• W2616815974 hasConcept C2780252810 @default.
• W2616815974 hasConcept C2780303639 @default.
• W2616815974 hasConcept C2781307858 @default.
• W2616815974 hasConcept C2908647359 @default.
• W2616815974 hasConcept C2911091166 @default.
• W2616815974 hasConcept C51785407 @default.
• W2616815974 hasConcept C71924100 @default.
• W2616815974 hasConcept C79484868 @default.
• W2616815974 hasConcept C8891405 @default.
• W2616815974 hasConcept C99454951 @default.
• W2616815974 hasConceptScore W2616815974C126322002 @default.
• W2616815974 hasConceptScore W2616815974C203014093 @default.
• W2616815974 hasConceptScore W2616815974C2776090121 @default.
• W2616815974 hasConceptScore W2616815974C2777702733 @default.
• W2616815974 hasConceptScore W2616815974C2778296632 @default.
• W2616815974 hasConceptScore W2616815974C2779727006 @default.
• W2616815974 hasConceptScore W2616815974C2780252810 @default.
• W2616815974 hasConceptScore W2616815974C2780303639 @default.
• W2616815974 hasConceptScore W2616815974C2781307858 @default.
• W2616815974 hasConceptScore W2616815974C2908647359 @default.
• W2616815974 hasConceptScore W2616815974C2911091166 @default.
• W2616815974 hasConceptScore W2616815974C51785407 @default.
• W2616815974 hasConceptScore W2616815974C71924100 @default.
• W2616815974 hasConceptScore W2616815974C79484868 @default.
• W2616815974 hasConceptScore W2616815974C8891405 @default.
• W2616815974 hasConceptScore W2616815974C99454951 @default.
• W2616815974 hasIssue "5S-3" @default.
• W2616815974 hasLocation W26168159741 @default.
• W2616815974 hasOpenAccess W2616815974 @default.
• W2616815974 hasPrimaryLocation W26168159741 @default.
• W2616815974 hasRelatedWork W136737509 @default.
• W2616815974 hasRelatedWork W1991036943 @default.
• W2616815974 hasRelatedWork W1998003739 @default.
• W2616815974 hasRelatedWork W2007286155 @default.
• W2616815974 hasRelatedWork W2075902442 @default.
• W2616815974 hasRelatedWork W2355459301 @default.
• W2616815974 hasRelatedWork W3030688653 @default.
• W2616815974 hasRelatedWork W3118545484 @default.
• W2616815974 hasRelatedWork W3158484568 @default.
• W2616815974 hasRelatedWork W4290034612 @default.
• W2616815974 hasVolume "101" @default.
• W2616815974 isParatext "false" @default.
• W2616815974 isRetracted "false" @default.
• W2616815974 magId "2616815974" @default.
• W2616815974 workType "article" @default.